Statistics for EVALUATION OF F16 AS A NOVEL ANTIANGIOGENIC AGENT FOR GLIOBLASTOMA TREATMENT

Total visits

views
EVALUATION OF F16 AS A NOVEL ANTIANGIOGENIC AGENT FOR GLIOBLASTOMA TREATMENT 6

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
DissertationsSDL/79273/Dissertation.pdf 3

Top country views

views
Netherlands 4
Saudi Arabia 1

Top city views

views
Amsterdam 4
Riyadh 1

Copyright owned by the Saudi Digital Library (SDL) © 2025